Alamar Biosciences indicated to open at $20, IPO priced at $17

Alamar Biosciences (ALMR) priced 11.25M shares at $17.00. The deal size was increased to 11.25M shares of common stock from 9.375M shares and priced at the high-end of the $15.00-$17.00 range. JPMorgan, BofA, TD Cowen, Leerink and Stifel acted as joint book running managers for the offering. Alamar is a life sciences company that says its platform is designed to detect biomarkers with ultra-high sensitivity and “address key limitations of existing technologies, helping researchers unlock the full spectrum of protein biomarkers across disease states.”